GOLDMAN SACHS GROUP INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 44 filers reported holding SUTRO BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$3,787,127
-25.9%
1,091,391
-0.7%
0.00%0.0%
Q2 2023$5,109,764
-26.3%
1,098,874
-26.8%
0.00%0.0%
Q1 2023$6,932,832
-20.4%
1,500,613
+39.3%
0.00%
-50.0%
Q4 2022$8,705,941
+66.7%
1,077,468
+14.6%
0.00%
+100.0%
Q3 2022$5,221,000
+98.1%
940,571
+85.9%
0.00%0.0%
Q2 2022$2,636,000
-20.3%
506,060
+25.8%
0.00%0.0%
Q1 2022$3,308,000
-38.7%
402,381
+11.0%
0.00%0.0%
Q4 2021$5,395,000
-12.4%
362,553
+11.2%
0.00%0.0%
Q3 2021$6,161,000
+537.1%
326,157
+527.2%
0.00%
Q2 2021$967,000
-42.1%
52,006
-29.1%
0.00%
Q1 2021$1,670,000
-42.1%
73,393
-44.8%
0.00%
-100.0%
Q4 2020$2,885,000
+1485.2%
132,867
+632.3%
0.00%
Q3 2020$182,000
-42.2%
18,144
-55.3%
0.00%
Q2 2020$315,000
+121.8%
40,586
+191.3%
0.00%
Q1 2020$142,000
+11.8%
13,934
+20.9%
0.00%
Q4 2019$127,000
-70.1%
11,529
-59.3%
0.00%
Q3 2018$425,00028,3000.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders